TEVA - Teva Pharmaceutical ...About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $8.74 | Open | $8.53 |
| Volume | 2.62M | Market Cap | 9.994B |
| Yield | Last Dividend |
| Prostate Cancer Therapeutics Market Like... | 10/27/20 |
| Data Bridge Market Research has added an exhaustive research study of the Prostate Cancer Therapeutics Market detailing every single market driver and... | |
| Know How Healthcare Nanotechnology Marke... | 10/27/20 |
| Healthcare Nanotechnology Market is expected to reach +13% CAGR during forecast period 2020-2027. A comprehensive analysis of global Healthcare Nanote... | |
| Biosimilars Market Top Key Players-Boehr... | 10/27/20 |
| Summary of the Biosimilars Market Report Due to the various economic, technological, research & development and geographical aspects, the Biosimilars ... | |
| Specialty Generics Market Worth Observin... | 10/27/20 |
| A new business intelligence report released by HTF MI with title "Global Specialty Generics Market Report 2020 by Key Players, Types, Applications, Co... | |
| Cardiovascular Risk Reduction Market Wor... | 10/27/20 |
| Cardiovascular Risk Reduction Market research report is formulated with the exact understanding of customer requirements. Market status at the global ... | |
| Wolff Parkinson White Syndrome Market De... | 10/26/20 |
| Global Wolff Parkinson white syndrome market is registering a steady CAGR of 3.76 % in the forecast period of 2019-2026. The report contains data of t... | |
| Teva Pharmaceutical Industries (NYSE:TEV... | 10/24/20 |
| Raymond James reissued their buy rating on shares of Teva Pharmaceutical Industries (NYSE:TEVA) in a research note released on Friday morning, Analyst... | |
| Teva Pharmaceutical Industries (NYSE:TEV... | 10/23/20 |
| Zacks Investment Research upgraded shares of Teva Pharmaceutical Industries (NYSE:TEVA) from a sell rating to a hold rating in a report issued on Tues... | |
| ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, R... | 10/23/20 |
| Share this Stock Information NEW YORK, Oct. 23, 2020 (GLOBE NEWSWIRE) ??? Rosen Law Firm, a global investor rights law firm, reminds the purchasers of... | |
| Teva Pharmaceutical Industries (NYSE:TEV... | 10/23/20 |
| Zacks Investment Research upgraded shares of Teva Pharmaceutical Industries (NYSE:TEVA) from a sell rating to a hold rating in a research note publish... | |
| Active Pharmaceutical Ingredients (API) ... | 10/23/20 |
| The Active Pharmaceutical Ingredients (API) Market Research Report delivers all-inclusive analysis of the market structure along with forecast of the ... | |
| Brokers Offer Predictions for Teva Pharm... | 10/23/20 |
| Teva Pharmaceutical Industries Limited (NYSE:TEVA) ??? Equities researchers at SVB Leerink upped their FY2020 earnings per share estimates for shares ... | |
| Sale of Teva's Jerusalem tablets plant c... | 10/22/20 |
| The Levinstein group was to have bought the Har Hotzvim property for NIS 171 million. | |
| THE DIGITAL THERAPEUTICS EXPLAINER: How ... | 10/22/20 |
| Summary List Placement This is a preview of The Digital Therapeutics research report from Business Insider Intelligence. Purchase this report. Busines... | |
| COVID-19 UPDATE: Global Prostate Cancer ... | 10/22/20 |
| A most recent review on Global Prostate Cancer Therapeutics Market is led covering different associations of the business from various topographies to... | |
| Q3 2020 Earnings Estimate for Teva Pharm... | 10/22/20 |
| Teva Pharmaceutical Industries Limited (NYSE:TEVA) ??? Research analysts at SVB Leerink cut their Q3 2020 earnings per share (EPS) estimates for share... | |
| Global Opioid Use Disorder Market (Covid... | 10/22/20 |
| Data Bridge Market Research has recently added a concise research on the Global Opioid Use Disorder Market- Industry Trends and Forecast to 2026. A re... | |
| Teva Pharmaceutical Industries (NYSE:TEV... | 10/22/20 |
| Teva Pharmaceutical Industries (NYSE:TEVA) was upgraded by Zacks Investment Research from a ???sell??? rating to a ???hold??? rating in a report relea... | |
| Zacks Investment Research Upgrades Teva ... | 10/21/20 |
| Teva Pharmaceutical Industries (NYSE:TEVA) was upgraded by Zacks Investment Research from a ???sell??? rating to a ???hold??? rating in a research not... | |
| SVB Leerink Comments on Teva Pharmaceuti... | 10/21/20 |
| Teva Pharmaceutical Industries Limited (NYSE:TEVA) ??? Research analysts at SVB Leerink boosted their FY2020 earnings per share (EPS) estimates for Te... | |
| Ependymoma Treatment Market Share, Growt... | 10/21/20 |
| Ependymoma Treatment Market report analyzes the market status, market share, current trends, growth rate, future trends, market drivers, opportunities... | |
| Global Narcolepsy Treatment Market 2020:... | 10/21/20 |
| Global narcolepsy treatment market is expected to grow at a healthy CAGR in the forecast period of 2019-2026. Increase in demand of targeted mode of t... | |
| Global Nootropics Market 2020: Covid-19 ... | 10/21/20 |
| Global Nootropics Market Research Report has been analyzed in detail to help clients with all the vital data to frame tactical business judgments and ... | |
| Teva, Amazon Web Services and Onica Anno... | 10/21/20 |
| TEL AVIV, Israel & PARSIPPANY, N.J. & SAN ANTONIO--(BUSINESS WIRE)--Teva Respiratory, LLC, an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE a... | |
| Editor???s Pick: These Teva slip-ons are... | 10/20/20 |
| Teva???s Ember Mocs strike the perfect balance between sneaker and slipper. When you think of Teva, you probably think of strappy, hike-ready utility ... | |
| Male Hypogonadism Market to 2027 - AbbVi... | 10/20/20 |
| A report by The Insight Partner's on the Male Hypogonadism Market discusses the growth of the market in great detail. It discusses thoroughly all fact... | |
| Major Boost to the Global Esomeprazole M... | 10/20/20 |
| The growing demand for Esomeprazole Magnesium has provided a major boost to the Global Esomeprazole Magnesium Market as more people are shifting their... | |
| Teva Pharmaceutical Industries (NYSE:TEV... | 10/20/20 |
| Teva Pharmaceutical Industries (NYSE:TEVA) was upgraded by Zacks Investment Research from a ???sell??? rating to a ???hold??? rating in a report issue... | |
| Global Eating Disorder Market 2020:Share... | 10/20/20 |
| The latest 350+ page survey report on Global Eating Disorder Imaging Market is released by Data Bridge Market Research covering various players of the... | |
| Global Pseudobulbar treatment Market Gro... | 10/20/20 |
| Pseudobulbar treatment Market Report contains key drivers and Restraints of the market with their information and market competition situation among t... | |
| Buy rating | 08/06/20 |
| SVB Leerink maintains Market Perform rating and raises Price Target from $13.00 to $14.00 | |
| Hold rating | 08/06/20 |
| Barclays upgrades from Underweight to Equal-Weight rating and announces Price Target of $13.00 | |
| Date | 2020-08-05 (BMO) | Est. (EPS/Rev.) | $0.53/ 3.93B |
| Actual (EPS/Rev.) | $0.55/ $3.87 B | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Trading | Trading | 99.00 % | Follow |
| Free Biotech Holdings | Scientia Equity Research | 83.00 % | Follow |
| Equity and Teens | Equity and Teens | 73.00 % | Follow |
| Swing for the fences | Gino Baldassano | 72.00 % | Subscribe |
| Arbitrage Trade Analytics | Royce Wells | 71.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
